| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |